Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
11/2010
11/18/2010WO2009151708A3 Peptide analogs of alpha-melanocyte stimulating hormone
11/18/2010US20100292148 Targeted polylysine dendrimer therapeutic agent
11/18/2010US20100291680 Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission
11/17/2010EP2251344A1 Formulation of boronic acid compounds
11/17/2010EP1907860B1 Mass labels
11/17/2010EP1628956B1 A process for the preparation of compounds having an ace inhibitory action
11/16/2010US7834146 Recombinant polypeptides associated with plants
11/16/2010US7834043 Prevent reproduct of aids virus
11/16/2010US7833986 Dipeptides and tripeptides for treating inflammatory reactions, including allergic reactions associated with asthma, rhinitis, conjunctivitis, atopic dermatitis and intestinal anaphylaxis; cyclohexylalanine-L-glutamic acid-glycine
11/16/2010US7833985 tripeptides as hypotensive agent for reducing blood pressure; edible; being of food origin; from sesame meal
11/16/2010US7833967 polypeptide having antimicrobial activity, having an amino acid sequence selected from e.g. Arg Arg Arg Pro Pro Arg Leu Pro Arg Pro Phe Pro; Phe Arg Pro Pro Pro Arg Pro Arg Pro Leu Pro Val; detergents, animal feed
11/16/2010CA2315878C Kappa receptor opioid peptides
11/11/2010US20100286367 Conjugates of soluble peptidic compounds with membrane-binding agents
11/11/2010US20100286064 Polypeptide inhibiting transmigration of leukocytes or growth and/or metastasis of cancer cells, and fusion protein thereof
11/11/2010US20100286036 Novel peptides that enhance tight junction permeability
11/11/2010US20100285535 Pcr hot start by magnesium sequestration
11/11/2010US20100285003 Therapeutic peptides and uses thereof
11/11/2010US20100284934 Diagnostic agent
11/10/2010EP2248821A1 Substrate for assaying -glucan and/or endotoxin and assay method
11/10/2010EP2247298A2 Control of viral-host membrane fusion with hydrogen bond surrogate-based artificial helices
11/10/2010EP1381627B1 Polypeptides derived from amyloid precursor peptide (app) and their uses
11/10/2010CN101883779A Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides
11/10/2010CN101883576A A micro-rna family that modulates fibrosis and uses thereof
11/10/2010CN101880314A Bursin-like peptide of gene engineering as well as expression gene and application thereof
11/10/2010CN101134773B Method for extracting corn free radical scavenger
11/09/2010US7829688 nucleic acid encoding peptide that inhibits the interaction of CaV2.2 with Mint1-PDZ1, a glutathione S transferase fusion protein; neurotransmitter-release angonists of CaV2.2, the pore-forming subunit of N-type of voltage-dependent calcium channels; antinocciceptive agents
11/09/2010US7829669 Catalytically active recombinant memapsin and methods of use thereof
11/09/2010US7829662 BH3 interacting domain death agonist for use in prevention ans treatment of apoptosis associated disorders
11/09/2010US7829564 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/09/2010US7829297 selecting therapy for a human subject having a solid epithelial tumor that overexpresses ErbB2 comprising determining whether the tumor expresses p95ErbB2; reversible dual tyrosine kinase inhibitor of both ErbB2 and epidermal growth factor receptor
11/09/2010US7829064 antigen binding molecules conjugated to lipids, polymer carriers, micelles, nanoparticles or mixtures and effectors, used for therapy of diagnosis
11/09/2010CA2407659C Growth hormone secretagogues
11/09/2010CA2208420C Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission
11/04/2010WO2010126034A1 Novel compound, histone acetylase inhibitor, nuclear receptor transcription activation inhibitor, deuteromycetes belonging to genus penicillium, and production process
11/04/2010US20100280229 Polypeptide
11/04/2010US20100280221 Peptide production and purification process
11/04/2010US20100279955 Novel lipid tripeptide-based hydrogelator and hydrogel
11/04/2010US20100279343 Method for producing alpha-l-aspartyl-l-phenylalanine-beta-ester and method for producing alpha-l-aspartyl-l-phenylalanine-alpha-methyl ester
11/04/2010US20100278750 Polylysine dendrimer contrast agent
11/03/2010EP2245045A1 Peptide derivatives useful in the treatment, care or cleansing of the skin, mucosae, scalp or nails
11/03/2010EP2245015A1 Difluorinated tripeptides as hcv serine protease inhibitors
11/03/2010EP1599496B1 Hepatitis c inhibitor peptide analogs
11/03/2010CN101878019A Personal care and cosmetic composition containing tetrapeptides with the motifs gx1x2g, px1x2p, or px1x2k
11/03/2010CN101875683A Small molecule peptide-based cholesteric organic gel molecules and preparation method thereof
11/02/2010US7825227 Method for purification of a protein complex and identification of its components
11/02/2010US7825216 Phenylanine derivatives
11/02/2010US7825086 Acyclovir-peptide analogs
11/02/2010US7824687 Clustered multi-antigenic carbohydrate constructs, methods for their preparation, and uses thereof
11/02/2010US7824683 Methods for augmenting an immune response using anti-CD40 antibodies
11/02/2010CA2341520C Energy transfer dyes
10/2010
10/28/2010WO2010123085A1 Trapping compounds and method for identifying reactive metabolites
10/28/2010WO2010122673A1 Trapping compounds and method for identifying reactive metabolites
10/28/2010WO2010122423A2 Novel composition
10/28/2010WO2010122245A1 Bleaching peptide hydrolysate proteasome activator and compositions containing same
10/28/2010WO2010122244A1 Peptide hydrolysate proteasome activators and compositions containing same
10/28/2010US20100273943 Peptide conjugates and fluorescence detection methods for intracellular caspase assay
10/28/2010US20100273843 Heterocyclic self-immolative linkers and conjugates
10/28/2010US20100273817 Anti-cancer cyclopenta(g)quinazoline compounds
10/28/2010US20100273716 New uses for amino acid anticonvulsants
10/27/2010EP2243774A1 Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors
10/27/2010EP1355674B1 Oligo alkylene glycol or polyalkylene glycol-coupled thrombin inhibitors
10/27/2010CN101870719A Organic functional compound having disulfide chemical bond and steroids skeleton, preparation method thereof and use thereof
10/26/2010USRE41894 Hepatitis C inhibitor tri-peptides
10/26/2010US7820671 Peptidomimetic protease inhibitors
10/26/2010US7820624 which bind to human immature dendritic cells; non-viral transfection mixture comprising lipid component, polycationic nucleic acid-binding component, and peptide; gene expression inhibition; kits
10/26/2010US7820619 potentiate antimicrobial functions of leukocytes such as neutrophils; lower inherent mammalian cell toxicities, improved immunogenicity and shortness of duration of effectiveness due to biodegradation, retaining activity in plasma and serum; antibiotic resistance; pharmacokinetics
10/26/2010US7820617 Administering peptide to person sensitive to diabetes; measurement, calibration
10/26/2010US7820157 Retroviral vector comprising nucleotide sequences coding collagen domain for use in wound healing; tissue repair and engineering; regenerative medicine
10/21/2010WO2010119864A1 Peptide derivative
10/21/2010WO2010119192A1 Cosmetic and/or pharmaceutical composition comprising a relieving peptidic hydrolysate
10/21/2010WO2010119191A1 Cosmetic and/or pharmaceutical composition comprising a peptidic hydrolysate that can reinforce the barrier function
10/21/2010WO2010118880A1 Peptides used in the treatment and/or care of the skin and/or hair and their use in cosmetic or pharmaceutical compositions
10/21/2010US20100267946 Prodrugs of gaba analogs, compositions and uses thereof
10/21/2010US20100267927 Structure of the Insulin Receptor Ectodomain
10/21/2010US20100267651 T cell antigen receptor peptides
10/21/2010US20100267634 Anti-Viral Compounds
10/21/2010US20100267621 Antimicrobial Compounds and Formulations
10/21/2010US20100267609 Compounds which inhibit beta-secretase activity and methods of use thereof
10/21/2010US20100266677 Nucleic acid binding compounds and methods of use
10/21/2010US20100266641 Endophytic Fungi from Pteromischum Sp. Plant, Compounds and Methods of Use
10/21/2010US20100266503 Breast Cancer Methods, Medicaments and Agents
10/20/2010EP2241573A2 Peptide derivatives and cosmetic composition comprising the same
10/20/2010EP2241564A1 3,8-diaminotetrahydroquinoline derivative
10/20/2010EP2240506A1 Inhibitors of iap
10/20/2010EP2240505A1 Peptide for activating aquaporin synthesis
10/20/2010EP1699759B1 Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity
10/20/2010CN101863971A Metastin derivatives and use thereof
10/20/2010CN101863959A Technique for separating and purifying glutathione from fresh yeast
10/20/2010CN101863958A Induction of the mitochondrial permeability transition
10/19/2010US7816490 Peptide for use in the treatment of immunological defects and allergies; capable of inhibiting protein-protein interaction between calcineurin and NFAT
10/19/2010US7816377 such as 1-methyl-piperidin-2-carbonsaure-[1-({1-[2-hydroxy-2-(4-phenethylcarbamoyl-thiazol-2-yl)-ethyl]-2-methyl-propyl}-methylcarbamoyl)-2-methyl-butyl]-amide, used for the treatement of adenocarcinoma
10/19/2010US7816327 Topical administration for therapy of exposure to urushiol; irritating oils such as catechol-containing plant-derived antigens such as poison ivy, poison oak, poison sumac and Asian lacquer tree and oils containing capsaicin
10/19/2010US7816317 Tripeptide prodrug compounds
10/19/2010CA2437081C Protein hydrolysates enriched in peptides having a carboxy terminal proline residue
10/19/2010CA2356845C Novel depsipeptide compound
10/19/2010CA2286722C Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors
10/19/2010CA2266757C Process for preparing pharmacologically acceptable salts of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanyl-amino acids
10/14/2010WO2010117725A2 Production of peptides containing poly-gly sequences using fmoc chemistry
10/14/2010WO2010116248A1 Organic compounds and their uses
10/14/2010WO2010116173A1 Depsipeptides and their therapeutic use
1 ... 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 ... 307